Seelos Therapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$0 N/A	$0 0%	$2.20M 0%	Avg: $28.4M Low: $28.4M High: $28.4M avg. 1189.15%	Avg: $86.1M Low: $86.1M High: $86.1M avg. 203.16%	Avg: $144.9M Low: $144.9M High: $144.9M avg. 68.29%
Net Income % change YoY	$-67.53M N/A	$-76.13M -12.74%	$-37.88M 50.24%	Avg: $670.35M Low: $670.35M High: $670.35M avg. 1869.57%	Avg: $0 Low: $0 High: $0 avg. -100%	Avg: $0 Low: $0 High: $0 avg. 0%
EBITDA % change YoY	$-61.32M N/A	$-73.75M -20.27%	$-37.75M 48.81%	Avg: $5.67M Low: $5.67M High: $5.67M avg. 115.04%	Avg: $17.21M Low: $17.21M High: $17.21M avg. 203.16%	Avg: $28.97M Low: $28.97M High: $28.97M avg. 68.29%
EPS % change YoY	-$22.29 N/A	-$21.48 3.63%	-$7.73 64.01%	Avg: $136.8 Low: $136.8 High: $136.8 avg. 1869.72%	Avg: $0 Low: $0 High: $0 avg. -100%	Avg: $0 Low: $0 High: $0 avg. 0%
Operating Expenses % change YoY	$61.66M N/A	$70.91M 14.99%	$12.58M -82.25%	Avg: $163.83M Low: $163.83M High: $163.83M avg. 1201.82%	Avg: $496.69M Low: $496.69M High: $496.69M avg. 203.16%	Avg: $835.90M Low: $835.90M High: $835.90M avg. 68.29%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 623.19% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is 670.35M, average is 670.35M and high is 670.35M.

Wall Street analysts forecast annual average revenue growth of 486.87% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $28.4M, average is $28.4M and high is $28.4M.

Wall Street analysts forecast annual average earnings growth of 623.24% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $136.8, average is $136.8 and high is $136.8.